Hurley Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19K Hold
445
0.01% 276
2026
Q1
$27.9K Sell
445
-100
-18% -$8K 0.02% 225
2025
Q4
$52K Buy
545
+100
+22% +$9.8K 0.03% 170
2025
Q3
$43.4K Sell
445
-49
-10% -$5.07K 0.02% 209
2025
Q2
$53.1K Hold
494
0.04% 152
2025
Q1
$49.8K Hold
494
0.04% 170
2024
Q4
$44.8K Buy
+494
New +$43.5K 0.04% 155

Other funds holding BSX

Hurley Capital's BSX Position: Q2 2026 in Review

Hurley Capital held its Boston Scientific (BSX) position steady in Q2 2026 at 445 shares worth $19K. The position accounts for 0.01% of the portfolio, ranked #276.

Hurley Capital first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $53.1K in Q2 2025. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Hurley Capital held 445 shares of Boston Scientific worth $19K as of Q2 2026.
  • Hurley Capital left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up 0.01% of Hurley Capital's portfolio in Q2 2026, its #276 holding.
  • Hurley Capital first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Hurley Capital's Boston Scientific position peaked at $53.1K in Q2 2025.
  • 1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Hurley Capital's 13F filing for Q2 2026, filed 10 Aug 2026.